(Q33265910)

24 July 2017

1 reference

title

Medical treatment of diabetic retinopathy with somatostatin analogues (English)

1 reference

24 July 2017

1 reference

4

Maria B Grant

1 reference

24 July 2017

Stela S Palii

1

1 reference

24 July 2017

Sergio Caballero

series ordinal

2

1 reference

24 July 2017

Gideon Shapiro

series ordinal

3

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Expert Opinion on Investigational Drugs

24 July 2017

published in

1 reference

24 July 2017

volume

16

1 reference

24 July 2017

issue

1

1 reference

24 July 2017

page(s)

73-82

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Increased plasma levels of thioredoxin in patients with glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

New concepts in pathogenesis and treatment of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Protein kinase C and the development of diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin (SRIF) and SRIF receptors in the mouse retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin and somatostatin receptors in retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin Analogs in Medical Treatment of Acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Molecular defects in the growth hormone-IGF axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Clinical relevance of systemic and local IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Insulin-like growth factors in the fed and fasted states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Serum-insulin in remission of juvenile diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Hypophysectomy in man; further experiences in severe diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Hypophysectomy in man: experiences in severe diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Occurrence and prevalence of diabetic retinopathy in hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

IGF-I mRNA and signaling in the diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Inhibition of endothelial proliferation by the somatostatin analogue SOM230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Development of Targeted Somatostatin-Based Antiangiogenic Therapy: A Review and Future Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Growing vascular endothelial cells express somatostatin subtype 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin and its receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Somatostatin analogs inhibit neonatal retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Octreotide, a somatostatin analogue, fails to inhibit hypoxia-induced retinal neovascularization in the neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.1.73

21 January 2018

Identifiers

DOI

10.1517/13543784.16.1.73

1 reference

release_7i7dys6hfngmtfvzhh3aza6vhe

24 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7i7dys6hfngmtfvzhh3aza6vhe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference